Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-020585

Chief Executive Officer sold 8,800 shares at an average $42.13 ($370,748)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ciechanover Isaac E. Chief Executive Officer 2018-03-15 Sale −2,800 $41.87 $117,236 221,278 I
Ciechanover Isaac E. Chief Executive Officer 2018-03-15 Sale −1,600 $42.95 $68,720 219,678 I
Ciechanover Isaac E. Chief Executive Officer 2018-03-16 Sale −3,100 $41.75 $129,425 216,578 I
Ciechanover Isaac E. Chief Executive Officer 2018-03-16 Sale −1,300 $42.59 $55,367 215,278 I
Open-market sales · 8,800 sh · avg $42.13 · $370,748
Loading xslF345X03/doc4.xml…